[VIRTUAL] A new therapeutic antibody against CD73 that ameliorates the tumor microenvironment and improves the efficacy of cancer immunotherapy

BP1200 - BrightPath Biotherap

T. Obonai; H. Ban; Y. Mishima; N. Matsumoto; M. Tsukahara; R. Kuniyoshi; N. Nakamura

Jul 22, 2021